John B. Buse

Endocrinology, Diabetes and Metabolism · 2003–2023

A researcher in the Science corpus: 40 papers; trusts 5 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

Endocrinology, Diabetes and Metabolism — 430 citations into it; #132 of 623 by trust here, #2 by citations
Surgery — 162 citations into it; #1,090 of 1,106 by trust here, #82 by citations
Molecular Biology — 115 citations into it
Epidemiology — 53 citations into it

Whom John B. Buse trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts John B. Buse overall

Papers from John B. Buse's perspective

Ordered by how strongly the researchers John B. Buse trusts endorse each paper. Same corpus, a different order for every researcher.

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. (The Lancet)
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. (Cochrane Database of Systematic Reviews)
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. (The Lancet)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes… (Diabetologia)
Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials (Journal of the American Medical Association (JAMA))
Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360,…
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (New England Journal of Medicine)
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (Diabetes Care)
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
A randomized trial of a low-carbohydrate diet for obesity. (New England Journal of Medicine)

Their papers

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2006) — 954 citations
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) — 2,670 citations
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2014) — 2,951 citations
Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery (2015) — 731 citations
Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. (2003) — 603 citations
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. (2023) — 670 citations
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (2022) — 1,624 citations
Causal role of frontal-midline theta in cognitive effort: a pilot study. (2021)
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2019) — 703 citations
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2019) — 1,044 citations
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2018) — 1,304 citations
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2018) — 2,795 citations
Effects of Once‐Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes (2017) — 1,746 citations
Liraglutide and Renal Outcomes in Type 2 Diabetes (2017) — 656 citations
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. (2015) — 2,285 citations
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition (2015) — 760 citations
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes (2015) — 732 citations
Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2013) — 2,521 citations
Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 (2013) — 1,101 citations
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) — 3,782 citations